Roswell Park to open $98M cell and gene therapy manufacturing facility

Roswell Park earns “exceptional” rating from NCI with best-ever core grant

Roswell Park Comprehensive Cancer Center has earned the highest—”exceptional”—rating from NCI as part of renewal of the grant the institution has held since 1972.

June 14, 2024

Vol.50 No.24

In Brief

City of Hope Atlanta opens Blood and Marrow Transplantation and Cell Therapy Program

City of Hope has opened a Blood and Marrow Transplantation and Cell Therapy Program at City of Hope Cancer Center Atlanta.

March 29, 2024

Vol.50 No.13

In Brief

A. Samer Al-Homsi named system chief of blood and marrow transplant and cellular therapy at Northwell

A. Samer Al-Homsi, a leader in hematology, was appointed as system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute.

March 29, 2024

Vol.50 No.13

Clinical

First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval

In a major breakthrough in cellular therapy, FDA has approved the first tumor-infiltrating lymphocyte therapy for patients with unresectable or metastatic melanoma who have received prior treatment, including with checkpoint inhibitors.

February 23, 2024

Vol.50 No.08

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Steven Rosenberg, Friedrich Graf Finckenstein: FDA recognition of TIL therapy is the result of 40 years of research

Feb. 16, 2024, is a landmark date in the history of immuno-oncology.

February 23, 2024

Vol.50 No.08

By Matthew Bin Han Ong

In Brief

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

Damian Green will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services. Green was named chief of the Division of Transplantation & Cellular Therapy, as well as assistant director of Translational Research, beginning March 1.

February 23, 2024

Vol.50 No.08

Roswell Park to open $98M cell and gene therapy manufacturing facility

YOU MAY BE INTERESTED IN

Roswell Park earns “exceptional” rating from NCI with best-ever core grant

City of Hope Atlanta opens Blood and Marrow Transplantation and Cell Therapy Program

A. Samer Al-Homsi named system chief of blood and marrow transplant and cellular therapy at Northwell

First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval

Steven Rosenberg, Friedrich Graf Finckenstein: FDA recognition of TIL therapy is the result of 40 years of research

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

Renew today!

Subscriber content

Login